An oral vaccine may be advantageous over an injectable vaccine for a pathogen because

• A. reduces the risk of transmitting bloodborne pathogens in developing areas of the world.
• B. avoids the pain associated with injections.
• C. induces mucosal immunity.
• D. all of the above.

Answer: (D)

Oral vaccination leverages the immune defenses at mucosal surfaces while avoiding injections, bringing several practical and immune advantages. Because vaccines are not given with needles, there is no risk from needle reuse or contaminated syringes, which lowers the chance of transmitting bloodborne pathogens—an important consideration in settings with limited sterile technique. It also sidesteps the pain and discomfort associated with injections, which can improve acceptance and coverage in communities. In addition, oral vaccines engage the gut-associated lymphoid tissue and induce mucosal immunity, including secretory IgA, providing a first line of defense right at the common entry point for many pathogens and potentially reducing transmission and infection. Taken together, these benefits explain why all of the above is the best answer.